Trexquant Investment LP Omeros Corp Transaction History

Trexquant Investment LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.92 - $6.28 $67,566 - $220,999	-35,191 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$5.07 - $7.2 $178,418 - $253,375	35,191 New	35,191 $211,000
Q3 2021 Nov 12, 2021	SELL	$13.4 - $16.3 $407,092 - $495,194	-30,380 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$14.81 - $19.13 $174,994 - $226,040	11,816 Added 63.65%	30,380 $451,000
Q1 2021 May 13, 2021	SELL	$14.52 - $23.53 $147,813 - $239,535	-10,180 Reduced 35.42%	18,564 $330,000
Q4 2020 Feb 11, 2021	BUY	$10.14 - $15.19 $291,464 - $436,621	28,744 New	28,744 $411,000
Q3 2020 Nov 06, 2020	SELL	$9.57 - $21.32 $130,113 - $289,866	-13,596 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$12.21 - $16.99 $387,203 - $538,786	-31,712 Reduced 69.99%	13,596 $200,000
Q1 2020 May 08, 2020	BUY	$9.03 - $19.72 $409,131 - $893,473	45,308 New	45,308 $606,000
Q1 2018 May 03, 2018	SELL	$9.0 - $20.16 $102,789 - $230,247	-11,421 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$13.26 - $22.86 $151,442 - $261,084	11,421	11,421 $222,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $634M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.